View Future GrowthOrchasp 과거 순이익 실적과거 기준 점검 3/6Orchasp의 수입은 연평균 -33.4%의 비율로 감소해 온 반면, Software 산업은 수입이 연평균 16.8% 증가했습니다. 매출은 연평균 3.1%의 비율로 감소해 왔습니다. Orchasp의 자기자본이익률은 3.5%이고 순이익률은 15.1%입니다.핵심 정보-33.36%순이익 성장률-27.71%주당순이익(EPS) 성장률Software 산업 성장률22.64%매출 성장률-3.07%자기자본이익률3.51%순이익률15.12%다음 순이익 업데이트27 May 2026최근 과거 실적 업데이트공시 • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.공시 • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.공시 • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.모든 업데이트 보기Recent updates공시 • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year.New Risk • Feb 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m).Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year.공시 • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026공시 • Dec 19Orchasp Limited announced that it expects to receive INR 86 million in fundingOrchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari.Buy Or Sell Opportunity • Dec 18Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.Buy Or Sell Opportunity • Nov 25Now 24% overvaluedOver the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.New Risk • Nov 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m).분석 기사 • Nov 21Does Orchasp (NSE:ORCHASP) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.공시 • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025New Risk • Oct 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m).공시 • Sep 01Orchasp Limited, Annual General Meeting, Sep 30, 2025Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time.Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.New Risk • Jul 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m).공시 • Jul 28Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025Reported Earnings • May 29Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024)Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024).공시 • May 19Orchasp Limited to Report Q4, 2025 Results on May 28, 2025Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m).Board Change • Feb 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역Orchasp가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NSEI:ORCHASP 매출, 비용 및 순이익 (INR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25262402030 Sep 25283432030 Jun 25254-1020031 Mar 25211-1052031 Dec 24176-1352030 Sep 24148-1402030 Jun 2413770031 Mar 2413272031 Dec 23195-103030 Sep 23207-13030 Jun 2321900031 Mar 2323543031 Dec 22234132030 Jun 2233342031 Mar 2237312031 Dec 21370212030 Jun 21178100031 Mar 219322031 Dec 20259-262030 Jun 20666-42031 Mar 20828172031 Dec 19801462030 Sep 19705502030 Jun 19648570031 Mar 19604622031 Dec 1848062424030 Sep 1846756424030 Jun 18540500031 Mar 181,047382031 Dec 171,40829115030 Sep 171,31429115030 Jun 171,16831115031 Mar 1753523115031 Dec 16122-675127030 Sep 16131-668127030 Jun 16128-674127031 Mar 16135-672144031 Dec 15140-2809030 Sep 15135-2869030 Jun 15130-28790양질의 수익: ORCHASP는 고품질 수익을 보유하고 있습니다.이익 마진 증가: ORCHASP는 과거에 흑자전환했습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: ORCHASP는 지난 5년 동안 흑자전환하며 연평균 -33.4%의 수익 성장을 기록했습니다.성장 가속화: ORCHASP는 지난해 흑자전환하여 5년 평균과 수익 성장률을 비교하기 어렵습니다.수익 대 산업: ORCHASP는 지난해 흑자전환하여 지난 해 수익 성장률을 Software 업계(8.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: ORCHASP의 자본 수익률(3.5%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSoftware 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 01:10종가2026/05/20 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Orchasp Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.
공시 • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.
공시 • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.
공시 • May 18Orchasp Limited to Report Q4, 2026 Results on May 27, 2026Orchasp Limited announced that they will report Q4, 2026 results on May 27, 2026
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹2.03, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 25x in the Software industry in India. Total loss to shareholders of 30% over the past year.
New Risk • Feb 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (₹262m revenue, or US$2.9m). Market cap is less than US$100m (₹920.3m market cap, or US$10.1m).
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.013 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.01 (down from ₹0.013 in 3Q 2025). Revenue: ₹43.8m (down 27% from 3Q 2025). Net income: ₹1.90m (down 62% from 3Q 2025). Profit margin: 4.3% (down from 8.3% in 3Q 2025). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹2.39, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 33x in the Software industry in India. Total loss to shareholders of 33% over the past year.
공시 • Feb 01Orchasp Limited to Report Q3, 2026 Results on Feb 10, 2026Orchasp Limited announced that they will report Q3, 2026 results at 9:15 AM, Indian Standard Time on Feb 10, 2026
공시 • Dec 19Orchasp Limited announced that it expects to receive INR 86 million in fundingOrchasp Limited in its Board Meeting announced a private placement of 26,875,000 Common Shares of the company at a price per share of INR 3.20 for gross proceeds of INR 86,000,000 on preferential basis on December 18, 2025. The transaction includes participation from individual investor Mrs. P. Rajeswari.
Buy Or Sell Opportunity • Dec 18Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 6.0% to ₹2.84. The fair value is estimated to be ₹2.29, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
Buy Or Sell Opportunity • Nov 25Now 24% overvaluedOver the last 90 days, the stock has fallen 2.7% to ₹2.88. The fair value is estimated to be ₹2.32, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 2.5% over the last 3 years. Meanwhile, the company has become profitable.
New Risk • Nov 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹850.0m (US$9.49m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (83% increase in shares outstanding). Market cap is less than US$10m (₹850.0m market cap, or US$9.49m). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Revenue is less than US$5m (₹283m revenue, or US$3.2m).
분석 기사 • Nov 21Does Orchasp (NSE:ORCHASP) Have A Healthy Balance Sheet?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: ₹0.01 (vs ₹0.37 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.01 (up from ₹0.37 loss in 2Q 2025). Revenue: ₹75.6m (up 65% from 2Q 2025). Net income: ₹2.08m (up ₹144.8m from 2Q 2025). Profit margin: 2.7% (up from net loss in 2Q 2025). The move to profitability was primarily driven by higher revenue.
공시 • Oct 28Orchasp Limited to Report Q2, 2026 Results on Nov 11, 2025Orchasp Limited announced that they will report Q2, 2026 results on Nov 11, 2025
New Risk • Oct 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 66% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Revenue is less than US$5m (₹254m revenue, or US$2.9m). Market cap is less than US$100m (₹1.20b market cap, or US$13.6m).
공시 • Sep 01Orchasp Limited, Annual General Meeting, Sep 30, 2025Orchasp Limited, Annual General Meeting, Sep 30, 2025, at 10:30 Indian Standard Time.
Reported Earnings • Aug 12First quarter 2026 earnings released: EPS: ₹0.02 (vs ₹0.007 in 1Q 2025)First quarter 2026 results: EPS: ₹0.02 (up from ₹0.007 in 1Q 2025). Revenue: ₹77.5m (up 123% from 1Q 2025). Net income: ₹5.42m (up 138% from 1Q 2025). Profit margin: 7.0% (up from 6.6% in 1Q 2025). The increase in margin was driven by higher revenue.
New Risk • Jul 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹156m free cash flow). Earnings have declined by 67% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$9.92m). Minor Risk Revenue is less than US$5m (₹211m revenue, or US$2.4m).
공시 • Jul 28Orchasp Limited to Report Q1, 2026 Results on Aug 11, 2025Orchasp Limited announced that they will report Q1, 2026 results on Aug 11, 2025
Reported Earnings • May 29Full year 2025 earnings released: ₹0.42 loss per share (vs ₹0.045 profit in FY 2024)Full year 2025 results: ₹0.42 loss per share (down from ₹0.045 profit in FY 2024). Revenue: ₹216.2m (up 63% from FY 2024). Net loss: ₹105.2m (down ₹112.0m from profit in FY 2024).
공시 • May 19Orchasp Limited to Report Q4, 2025 Results on May 28, 2025Orchasp Limited announced that they will report Q4, 2025 results on May 28, 2025
New Risk • Mar 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹859.6m (US$10.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (113% increase in shares outstanding). Market cap is less than US$10m (₹859.6m market cap, or US$10.00m). Minor Risk Revenue is less than US$5m (₹176m revenue, or US$2.0m).
Board Change • Feb 10Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Ravikishore Vithaleswara Bhattiprolu was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.